IL4R and breast cancer: In human breast cancer, cathepsin D (CTSD), IL4 receptor (IL4R), mucin-1 (MUC1, CD227), and serine protease 3 (PRSS3) may serve as valuable biomarkers for the diagnosis and treatment of breast cancer [20–23].